Most clinical trials involve the study of new drugs or procedures. They are carefully designed scientific processes designed to gather further information about these treatments, their safety, how well they work, and so on. There will already be a certain amount of knowledge available about these treatments, based on laboratory studies, or experience of their use in other illnesses. Clinical trials are usually designed to test a specific treatment in a specific situation.
The main purpose of our trials is to find better ways to diagnose or treat mantle cell lymphoma. These clinical trials are part of a long, careful research process. Clinical trials involving patients in the United Kingdom are very closely regulated by the National Patient Safety Agency research ethics committees (insert link). Those trials that involve medicinal products are closely regulated by the Medicines & Healthcare Products Regulatory agency, also known as the MHRA (insert link). Each hospital offering a particular clinical trial or research study to their patients also scrutinises the processes and paperwork before offering their patients the opportunity to take part. All staff with responsibility for caring for patients in clinical trials are required to have additional training in research governance and ethics.